BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 25939439)

  • 21. MicroRNA‑518b functions as a tumor suppressor in glioblastoma by targeting PDGFRB.
    Xu X; Zhang F; Chen X; Ying Q
    Mol Med Rep; 2017 Oct; 16(4):5326-5332. PubMed ID: 28849154
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
    Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
    Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-663 Suppresses Oncogenic Function of CXCR4 in Glioblastoma.
    Shi Y; Chen C; Yu SZ; Liu Q; Rao J; Zhang HR; Xiao HL; Fu TW; Long H; He ZC; Zhou K; Yao XH; Cui YH; Zhang X; Ping YF; Bian XW
    Clin Cancer Res; 2015 Sep; 21(17):4004-13. PubMed ID: 26023083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-29a inhibits glioblastoma stem cells and tumor growth by regulating the PDGF pathway.
    Yang Y; Dodbele S; Park T; Glass R; Bhat K; Sulman EP; Zhang Y; Abounader R
    J Neurooncol; 2019 Oct; 145(1):23-34. PubMed ID: 31482267
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-1297 regulates hepatocellular carcinoma cell proliferation and apoptosis by targeting EZH2.
    Liu F; He Y; Shu R; Wang S
    Int J Clin Exp Pathol; 2015; 8(5):4972-80. PubMed ID: 26191190
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reciprocal negative feedback loop between EZH2 and miR-101-1 contributes to miR-101 deregulation in hepatocellular carcinoma.
    Huang D; Wang X; Zhuang C; Shi W; Liu M; Tu Q; Zhang D; Hu L
    Oncol Rep; 2016 Feb; 35(2):1083-90. PubMed ID: 26718325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOX4 interacts with EZH2 and HDAC3 to suppress microRNA-31 in invasive esophageal cancer cells.
    Koumangoye RB; Andl T; Taubenslag KJ; Zilberman ST; Taylor CJ; Loomans HA; Andl CD
    Mol Cancer; 2015 Feb; 14():24. PubMed ID: 25644061
    [TBL] [Abstract][Full Text] [Related]  

  • 28. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma.
    Lu J; Zhao FP; Peng Z; Zhang MW; Lin SX; Liang BJ; Zhang B; Liu X; Wang L; Li G; Tian WD; Peng Y; He ML; Li XP
    Oncotarget; 2014 Nov; 5(22):11319-32. PubMed ID: 25237831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-32 functions as a tumor suppressor and directly targets EZH2 in human oral squamous cell carcinoma.
    Zhang D; Ni Z; Xu X; Xiao J
    Med Sci Monit; 2014 Dec; 20():2527-35. PubMed ID: 25472588
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carcinogenesis of intraductal papillary mucinous neoplasm of the pancreas: loss of microRNA-101 promotes overexpression of histone methyltransferase EZH2.
    Nakahara O; Takamori H; Iwatsuki M; Baba Y; Sakamoto Y; Tanaka H; Chikamoto A; Horino K; Beppu T; Kanemitsu K; Honda Y; Iyama K; Baba H
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S565-71. PubMed ID: 21932133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhancer of zeste homolog 2 silences microRNA-218 in human pancreatic ductal adenocarcinoma cells by inducing formation of heterochromatin.
    Li CH; To KF; Tong JH; Xiao Z; Xia T; Lai PB; Chow SC; Zhu YX; Chan SL; Marquez VE; Chen Y
    Gastroenterology; 2013 May; 144(5):1086-1097.e9. PubMed ID: 23395645
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroRNA-101 inhibits human hepatocellular carcinoma progression through EZH2 downregulation and increased cytostatic drug sensitivity.
    Xu L; Beckebaum S; Iacob S; Wu G; Kaiser GM; Radtke A; Liu C; Kabar I; Schmidt HH; Zhang X; Lu M; Cicinnati VR
    J Hepatol; 2014 Mar; 60(3):590-8. PubMed ID: 24211739
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-564 is downregulated in glioblastoma and inhibited proliferation and invasion of glioblastoma cells by targeting TGF-β1.
    Jiang C; Shen F; Du J; Hu Z; Li X; Su J; Wang X; Huang X
    Oncotarget; 2016 Aug; 7(35):56200-56208. PubMed ID: 27621042
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MiR-1271 regulates glioblastoma cell proliferation and invasion by directly targeting the CAMKK2 gene.
    Huang YK; Su YF; Lieu AS; Loh JK; Li CY; Wu CH; Kuo KL; Lin CL
    Neurosci Lett; 2020 Oct; 737():135289. PubMed ID: 32791096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-101 exerts tumor-suppressive functions in non-small cell lung cancer through directly targeting enhancer of zeste homolog 2.
    Zhang JG; Guo JF; Liu DL; Liu Q; Wang JJ
    J Thorac Oncol; 2011 Apr; 6(4):671-8. PubMed ID: 21270667
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2.
    Luo C; Merz PR; Chen Y; Dickes E; Pscherer A; Schadendorf D; Eichmüller SB
    Cancer Lett; 2013 Dec; 341(2):240-7. PubMed ID: 23962556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting miR-381-NEFL axis sensitizes glioblastoma cells to temozolomide by regulating stemness factors and multidrug resistance factors.
    Wang Z; Yang J; Xu G; Wang W; Liu C; Yang H; Yu Z; Lei Q; Xiao L; Xiong J; Zeng L; Xiang J; Ma J; Li G; Wu M
    Oncotarget; 2015 Feb; 6(5):3147-64. PubMed ID: 25605243
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MicroRNA-101 inhibits proliferation, migration and invasion of human glioblastoma by targeting SOX9.
    Liu N; Zhang L; Wang Z; Cheng Y; Zhang P; Wang X; Wen W; Yang H; Liu H; Jin W; Zhang Y; Tu Y
    Oncotarget; 2017 Mar; 8(12):19244-19254. PubMed ID: 27911279
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-340 impedes the progression of laryngeal squamous cell carcinoma by targeting EZH2.
    Yu W; Zhang G; Lu B; Li J; Wu Z; Ma H; Wang H; Lian R
    Gene; 2016 Feb; 577(2):193-201. PubMed ID: 26656176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of EZH2 reverses chemotherapeutic drug TMZ chemosensitivity in glioblastoma.
    Fan TY; Wang H; Xiang P; Liu YW; Li HZ; Lei BX; Yu M; Qi ST
    Int J Clin Exp Pathol; 2014; 7(10):6662-70. PubMed ID: 25400745
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.